Epidarex is pleased to announce the addition of Ryme Medical to our portfolio of medtech investments. Ryme is developing a unique catheter-based therapy that seeks to reduce
WALTHAM, Mass. and STOCKHOLM, Aug. 08, 2024 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi® (STO: SOBI) today announced positive topline results from the
Philadelphia, PA, August 5, 2024 – NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic inflammatory diseases through selective modulation of the NLRP3
– Greg brings over 25 years of public and private company leadership experience Philadelphia, PA, August 1, 2024 – NodThera, a leading clinical-stage biotech delivering a paradigm